ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 985 • 2013 ACR/ARHP Annual Meeting

    Efficacy Study Of Multimedia To Educate Rheumatoid Arthritis Patients

    Julie A. Unk, Rheumatology, Washington Univ School of Med, St. Louis, MO

    Abstract:   Efficacy study of multimedia to educate rheumatoid arthritis patients Background/Purpose: The level of health literacy varies among rheumatoid arthritis (RA) patients in their ability…
  • Abstract Number: 986 • 2013 ACR/ARHP Annual Meeting

    Participant and Educator Feedback Informs Delivery Of An Interprofessional Inflammatory Arthritis Education Program Using Telemedicine In Rural Communities

    Carol Kennedy1, Kelly Warmington2, Carol Flewelling3, Rachel Shupak4, Angelo Papachristos5, Caroline Jones5, Dorcas Beaton6,7, Sydney C. Lineker8 and Denise Linton9, 1Mobility Program Clinical Research Unit, St. Michael's Hospital, Toronto, ON, Canada, 2Learning Institute, The Hospital for Sick Children, Toronto, ON, Canada, 3St. Michael's Hospital, Toronto, ON, Canada, 4Internal Medicine, St. Michaels Hospital, Toronto, ON, Canada, 5Physiotherapy, St Michael's Hospital, Toronto, ON, Canada, 6Research, Mobility Program Clinical Research Unit, Li Ka Shing Knowledge Institute, St. Michaels Hospital, Toronto, ON, Canada, 7Scientist, Institute for Work & Health, Toronto, ON, Canada, 8The Arthritis Society, Toronto, ON, Canada, 9Mobility Clinical Research Unit, St. Michael's Hospital, Toronto, ON, Canada

    Background/Purpose: Telemedicine-based approaches to healthcare service delivery are known to improve access to care, as well as the efficiency, quality and timeliness of healthcare service…
  • Abstract Number: 987 • 2013 ACR/ARHP Annual Meeting

    Improving Access To Subspecialty Care For Underserved Communities: A Rheumatology Patient Navigator Pilot Intervention

    Candace H. Feldman1, Gregory A. Culley2, Erika Brown3, Chanele R. Assencoa2, LeRoi S. Hicks4 and Daniel H. Solomon3,5, 1Rheumatology, Immunology and Allergy, Brigham and Women's Hospital,Harvard Medical School, Boston, MA, 2Family Health Center of Worcester, Inc., Worcester, MA, 3Division of Rheumatology, Brigham and Women's Hospital, Boston, MA, 4Division of Hospital Medicine, UMass Memorial Medical Center, Worcester, MA, 5Division of Pharmacoepidemiology, Harvard Medical School, Brigham and Women's Hospital, Division of Rheumatology, Division of Pharmacoepidemiology, Boston, MA

    Background/Purpose: Early and sustained access to rheumatology care can improve access to disease-modifying medications and reduce disparities in outcomes. In one state, more than one-half…
  • Abstract Number: 988 • 2013 ACR/ARHP Annual Meeting

    Lupus Education For Providers Serving The Asian American Community:  Hospital For Special Surgery’s LANtern® (Lupus Asian Network) Initiative

    My-Lan N. Tran1, Roberta Horton2, Michael D. Lockshin3 and Arthur Yee4, 1Social Work Programs, Hospital for Special Surgery, New York City, NY, 2Department of Social Work Programs, Hospital for Special Surgery, New York, NY, 3Rheumatology, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, 4Rheumatology, Hospital for Special Surgery, New York, NY

    Background/Purpose: Lupus affects Asian Americans 2-3 times more than their white counterparts, with studies demonstrating health disparities in severity and outcomes. Our hospital’s national support…
  • Abstract Number: 989 • 2013 ACR/ARHP Annual Meeting

    Reproductive Counseling Program For Lupus Patients At The Systemic Lupus Erythematosus-Antiphospholipid Syndrome Center Of Excellence At Hospital For Special Surgery

    Katherine Kim1, Alana B. Levine2, Monica C. Richey2, Nadine H. Spring2, Elizabeth Schulman3, Lisa R. Sammaritano2, Shari E. Gelber4 and Jane E. Salmon2, 1Rheumatology, Hospital for Special Surgery, New York, NY, 2Rheumatology, Hospital for Special Surgery, New York, NY, 3Rheumatology, Hospital for Special Surgey, New York, NY, 4Obstetrics, New York Presbyterian Hospital, New York, NY

    Background/Purpose: Maternal exposure to mycophenolate mofetil (MMF) during pregnancy is associated with increased risks of first trimester pregnancy loss and congenital malformations. Responding to this…
  • Abstract Number: 951 • 2013 ACR/ARHP Annual Meeting

    The Anti-IL-17A Monoclonal Antibody Secukinumab (AIN457) Inhibits Pro-Inflammatory Mediator Release From Human Primary Synoviocytes Costimulated With IL-17 and TNF

    Christine Huppertz, Marija Curcic Djuric, Robert Hennze and Frank Kolbinger, Autoimmunity, Transplantation and Inflammatory Disease, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, SWITZERLAND, Basel, Switzerland

    Background/Purpose: Fibroblast-like synoviocytes (FLS) are targets of the pro-inflammatory IL-17 cytokines and a major source of inflammatory mediators in the inflamed synovium in rheumatoid arthritis…
  • Abstract Number: 968 • 2013 ACR/ARHP Annual Meeting

    Success Of Educational Intervention In Improving The Management Of Rheumatoid Arthritis

    Nimish Mehta and Ronald Viggiani, Medscape, LLC, New York, NY

    Background/Purpose: In many patients with rheumatoid arthritis (RA), the disease is not adequately controlled and only a minority of patients attain the goal of consistent…
  • Abstract Number: 969 • 2013 ACR/ARHP Annual Meeting

    Increasing Rheumatology Exposure To Internal Medicine Residents: 3 Year Analysis Of A Web-Based Image Of The Month

    Steven J. Katz, Rheumatology, University of Alberta, Edmonton, AB, Canada

    Background/Purpose: A previous study has demonstrated a web based Image of the Month can increase rheumatology exposure for internal medicine residents over 1 year with…
  • Abstract Number: 949 • 2013 ACR/ARHP Annual Meeting

    Targeting CD1c-Expressing Mdcs To Inhibit Tcell Activation and Thymus and Activation Regulated Chemokine (TARC)-Dependent Chemotaxis In RA

    M.R. Hillen1,2, F.M. Moret1,3, F.P.J.G. Lafeber4, C.E. Hack4, T.R.D.J. Radstake2,5 and J.A.G. van Roon3,6, 1Laboratory for Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 2Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 3Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 4Rheumatology & Clinical Immunology, UMC Utrecht, Utrecht, Netherlands, 5Laboratory for Translational Immunology, UMC Utrecht, Utrecht, Netherlands, 6Laboratory for Translational immunology, University Medical Center Utrecht, Utrecht, Netherlands

    Background/Purpose: Recently, we demonstrated strong Th1 and Th17 cytokine induction by CD1c+ myeloid dendritic cells (mDCs) from synovial fluid and identified thymic stromal lympopoeitin (TSLP)…
  • Abstract Number: 950 • 2013 ACR/ARHP Annual Meeting

    Changes In Circulating Visfatin Levels By Different Anti-Rheumatic Treatments: A Comparison Among Synthetic Disease Modifying Anti-Rheumatic Drugs, Tumor Necrosis Factor Blockade and B-Cell Depletion For Rheumatoid Arthritis

    Hana Hulejová1, Markéta Kuklová2, Herman F. Mann3, Mária Filková4, Olga Kryštufková5, Karel Pavelka6, Ondrej Sglunda7, Jiri Vencovsky8 and Ladislav Senolt8, 1Department of Clinical and Experimental Rheumatology, 1st Faculty of Medicine, Charles University, Institute of Rheumatology, Prague, Czech Republic, 2Institute of Rheumatology, Department of Experimental Rheumatology, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic, 3Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Prague, Czech Republic, 4Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic, 5Institute of Rheumatology, and Dept. of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic, 6Department of Clinical and Experimental Rheumatology, Charles University, Prague, Czech Republic, 7Institute of Rheumatology and Department of Rheumatology of the First Faculty of Medicine, Charles University in Prague, Czech Republic, Prague, Czech Republic, 8Department of Clinical and Experimental Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Institute of Rheumatology, Prague, Czech Republic

    Background/Purpose: Visfatin is an insulin mimetic adipokine that has been originally described as a pre-B cell colony-enhancing factor. Association between elevated visfatin levels, disease activity…
  • Abstract Number: 952 • 2013 ACR/ARHP Annual Meeting

    CX3CR1 Deficiency Attenuates Imiquimod-Induced Psoriasis-Like Skin Inflammation By Predominant Infiltration Of M2 Macrophages

    Sohshi Morimura1, Makoto Sugaya2 and Shinichi Sato3, 1Department of Dermatology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan, 2Dermatology, University of Tokyo Graduate School of Medicine, Tokyo, Japan, 3Department of Dermatology, Faculty of Medicine, University of Tokyo, Tokyo, Japan

    Background/Purpose: CX3C chemokine receptor 1 (CX3CR1), a receptor for CX3CL1, has been identified as a key mediator of macrophage migration into injured tissue or inflammation…
  • Abstract Number: 953 • 2013 ACR/ARHP Annual Meeting

    Baseline Serum Interleukin-34 Levels Predict Radiographic Progression In Rheumatoid Arthritis Patients

    Sung Hae Chang1,2, Byoung Youg Choi3, Hyon Joung Cho4, Hye Jin Oh5, Eun Ha Kang3, Yeong Wook Song2,6 and Yun Jong Lee2,7, 1Internal Medicine Rheumatology, Seoul National University Bundang Hospital, Seongnam-si, South Korea, 2Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea, 3Internal Medicine, Rheumatology, Seoul National University Bundang Hospital, Seongnam-si, South Korea, 4Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, South Korea, 5Internal Medicine, Rheumatology, Seoul National University Hospital, Seoul, South Korea, 6Internal Medicine,Rheumatology, Seoul National University Hospital, Seoul, South Korea, 7Division of Rheumatology, Department of Internal Medicine,Seoul National University Bundang Hospital, Seongnam, South Korea

    Background/Purpose: Interleukin-34 (IL-34), a novel cytokine playing a critical role in osteoclastogenesis, recently was reported that its expression increases in the synovial tissue and sera…
  • Abstract Number: 954 • 2013 ACR/ARHP Annual Meeting

    Correlating The In Vivo Production Of IFNγ To Disease Parameters In TLR9-Induced Macrophage Activation Syndrome (MAS) In Mice

    Vanessa Buatois1, Laurence Chatel1, Laura Cons1, Sabrina Lory1, Maureen Deehan1, Jennifer Sims2, Cristina de Min3, Marie Kosco-Vilbois1 and Walter Ferlin1, 1NovImmune S.A., Geneva, Switzerland, 2Integrated Biologix GmBH, Basel, Switzerland, 3Novimmmune S.A., Plan-Les-Ouates, Geneva, Switzerland

    Background/Purpose: Cytokine release is the hallmark feature in mice given repeated injections of the TLR9 agonist, CpG-containing oligodeoxynucleotides (CpG-ODN), resulting in pathology resembling the human…
  • Abstract Number: 955 • 2013 ACR/ARHP Annual Meeting

    Myeloid Deletion Of SIRT1 Aggravates Serum Transfer Arthritis But Ameliorate Collagen-Induced Arthritis

    Sang-Il Lee1, Yun-Hong Cheon2, Won Seok Lee2 and Ji-Min Kim3, 1Division of Rheumatology, Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, South Korea, 2Rheumatology, Department of Internal Medicine, Chonbuk National University Medical School and Research Institute of Clinical Medicine, Jeonju, South Korea, 3Division of Rheumatology, Department of Internal Medicine, Keimyung University School of Medicine, Daegu, South Korea

    Background/Purpose: SIRT1 plays a pivotal role in regulating the inflammatory response. Thus, we assessed the role of SIRT1 in K/BxN serum transfer arthritis as a…
  • Abstract Number: 957 • 2013 ACR/ARHP Annual Meeting

    The Role Of S100A4 As a Biological Marker Of Immune Response In Early Rheumatoid Arthritis

    Lucie Andrés Cerezo1, Klára Prajzlerová2, Martina Remáková1, Herman F. Mann3, Michal Tomcík2, Karel Pavelka4, Jiri Vencovsky2 and Ladislav Senolt2, 1Department of Clinical and Experimental Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Institute of Rheumatology, Prague, Czech Republic, 2Department of Clinical and Experimental Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Institute of Rheumatology, Prague, Czech Republic, 3Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Prague, Czech Republic, 4Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic

    Background/Purpose: We have previously demonstrated that S100A4 is up-regulated in established rheumatoid arthritis (RA) and that S100A4 regulates apoptosis and synthesis of matrix degrading enzymes…
  • « Previous Page
  • 1
  • …
  • 2365
  • 2366
  • 2367
  • 2368
  • 2369
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology